Bendeka
Term · Oncology and biomedicine · MLC-T-ONC-000982
A drug used to treat chronic lymphocytic leukemia and certain types of non-Hodgkin lymphoma. It is also being studied in the treatment of other types of cancer. Bendeka damages the cell’s DNA and may kill cancer cells. It is a type of alkylating agent. Also called Belrapzo, bendamustine hydrochloride, and Treanda.
| Identifier | MLC-T-ONC-000982 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | Belrapzo; bendamustine hydrochloride; Treanda |
| References | NCI Dictionary of Cancer Terms |
Record as JSON
{
"id": "MLC-T-ONC-000982",
"term": "Bendeka",
"field": "Oncology and biomedicine",
"definition": "A drug used to treat chronic lymphocytic leukemia and certain types of non-Hodgkin lymphoma. It is also being studied in the treatment of other types of cancer. Bendeka damages the cell’s DNA and may kill cancer cells. It is a type of alkylating agent. Also called Belrapzo, bendamustine hydrochloride, and Treanda.",
"synonyms": [
"Belrapzo",
"bendamustine hydrochloride",
"Treanda"
],
"references": [
"NCI Dictionary of Cancer Terms"
],
"url": "https://mlchart.com/terminology/oncology/bendeka/"
}
Record 3,424 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.